Do selective topical β antagonists for glaucoma have respiratory side effects?

British Journal of Ophthalmology

Volumn 88, Issue 2, 2004, Pages 196-198

  Kirwan, J F ^a,b   Nightingale, J A ^c   Bunce, C ^b   Wormald, R ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

AGED; AIRWAY OBSTRUCTION; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GLAUCOMA; HAZARD ASSESSMENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA; GREAT BRITAIN; HUMANS; INCIDENCE; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; RISK FACTORS;

EID: 0942268752     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2003.017715     Document Type: Article

References (19)

1. Mitchell P, Smith W, Attebo W, et al. Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology 1996;103:1661-9.
2. Dielemans I, Vingerling JR, Wolfs RC, et al. The prevalence of primary open-angle glaucoma in a population-based study in the Netherlands. The Rotterdam Study. Ophthalmology 1994;101:1851-5.
3. Tielsch JM, Katz J, Quigley HA, et al. Diabetes, intraocular pressure, and primary open-angle glaucoma in the Baltimore Eye Survey. Ophthalmology 1995;102:48-53.
4. Tielsch JM, Sommer A, Katz J, et al. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA 1991;266:369-74.
5. Kass MA, Heuer DK, Higginbotham EJ, et al. The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:701-13.
6. Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002;120:1268-79.
7. BMA & RPS. British National Formulary. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 1998.
8. Kirwan JF, Nightingale JA, Bunce C, et al. Beta blockers for glaucoma and excess risk of airways obstruction: population based cohort study. BMJ 2002;325:1396-7.
9. Weinreb RN, van Buskirk EM, Cherniack R, et al. Long-term betaxalol therapy in glaucoma patients with pulmonary disease. Am J Ophthalmol 1988;106:162-7.
10. Salpeter SR, Ormiston TM, Salpeter EE. Cardiaselective β-blockers in patients with reactive airway disease: a meta-analysis. Ann Intern Med 2002;137:715-25.
11. Salpeter SS, Ormiston T, Salpeter E, et al. Cardioselective β-blockers for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2002:CD003566.
12. IMS Health. Quality, validity, representativeness and completeness of data. London: IMS, 1999.
13. Lawrenson RA, Coles G, Walton K, et al. Characteristics of practices contributing to the Mediplus database and the implications for its use in epidemiological research. J Infomatics Prim Care 1998:14-18.
14. Dunn TL, Gerber MJ, Shen AS, et al. The effect of topical ophthalmic instillation of timolol and betaxolol on lung function in asthmatic subjects. Am Rev Respir Dis 1986;133:264-8.
15. Schoene RB, Abuan T, Ward RL, et al. Effects of topical betaxolol, timolol, and placebo on pulmonary function in asthmatic bronchitis. Am J Ophthalmol 1984;97:86-92.
16. Van Buskirk EM, Weinreb RN, Berry DP, et al. Betaxolol in patients with glaucoma and asthma. Am J Ophthalmol 1986;101:531-4.
17. Spiritus EM, Casciari R. Effects of topical betaxolol, timolol, and placebo on pulmonary function in asthmatic bronchitis [letter]. Am J Ophthalmol 1985;100:492-4.
18. Harris LS, Greenstein SH, Bloom AF. Respiratory difficulties with betaxolol. Am J Ophthalmol 1986;102:274-5.
19. Diggory P, Cassels-Brown A, Vail A, et al. Avoiding unsuspected respiratory side-effects of topical timolol with cardioselective or sympathomimetic agents. Lancet 1995;345:1604-6.